Jade Biosciences Inc
JBIOHealthcare|Biotechnology|USA
$20.94
-1.54 (-6.85%)
Tangible Book
$6.01
Upcoming Data Readouts (3)
May 2027
Est. completion
P1Healthy Volunteers (HV)
A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants
NCT07525947n=40
Oct 2027
Est. completion
P1Rhematoid Arthritis
A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis
NCT07533955n=36
Jan 2029
Est. completion
P2IgA Nephropathy
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
NCT07541287n=30
Awaiting Results (1)
Trials past primary completion date but still active — data readout may be imminent.